Metabolomic and lipidomic analyses reveal phosphatidylcholine–lysophosphatidylcholine axis alterations in sorafenib-persistent hepatocellular carcinoma

肝细胞癌 代谢组学 癌症研究 医学 化学 癌 生物 新陈代谢 癌症 代谢途径
作者
Meng Chieh Yang,Nichawadee Sandech,Sucheewin Krobthong,Likit Rangsirattanakul,Wisuit Pradidarcheep,Arnatchai Maiuthed
出处
期刊:Biomedicine & Pharmacotherapy [Elsevier BV]
卷期号:204: 119977-119977
标识
DOI:10.1016/j.biopha.2026.119977
摘要

Metabolic reprogramming and lipid remodeling are increasingly recognized as key processes underlying carcinogenesis and cancer treatment failure. The liver, as a central hub for lipid metabolism and homeostasis, is particularly susceptible to such alterations. Accordingly, hepatocellular carcinoma (HCC) exhibits extensive metabolic dysregulation and lipid remodeling, contributing to resistance to systemic therapies, including sorafenib. This study characterized histopathological and metabolic signatures across HCC carcinogenesis stages using a diethylnitrosamine/thioacetamide-induced rat model. Histopathological analysis confirmed gradual progression from inflammation to cirrhosis and finally HCC, based on non-alcoholic fatty liver disease activity scoring and non-alcoholic steatohepatitis fibrosis staging. Metabolomic profiling revealed stage-specific metabolic patterns throughout disease progression, with a marked shift toward lipid-centric metabolism during fibrosis and in sorafenib-persistent tumors, defined here as cancer cells that survive sorafenib treatment. These metabolic changes highlight the role of lipid remodeling in both early carcinogenesis and systemic treatment tolerance. Furthermore, lipidomic analysis of sorafenib-persistent HCC demonstrated significant accumulation of lysophosphatidylcholine (LPC)(20:4) and depletion of precursor phosphatidylcholine species, demonstrating alterations to the phosphatidylcholine-lysophosphatidylcholine axis. Given that cytosolic phospholipase A2 (cPLA2) is a key enzyme that hydrolyzes phosphatidylcholine to generate lysophosphatidylcholine, we hypothesized that cPLA2 may contribute to the observed lipid imbalance. Mechanistic validation in sorafenib-treated HepG2 cells using the cPLA2 inhibitor AACOCF3 showed increased sorafenib sensitivity, enhanced apoptosis, and reduced clonogenicity upon cPLA2 inhibition. Collectively, these findings identify phosphatidylcholine-lysophosphatidylcholine axis alteration as a potential driver of cancer cell survival under sorafenib treatment and highlight lipid metabolic reprogramming as a sorafenib-re-sensitization target in HCC.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
水波不兴完成签到 ,获得积分10
刚刚
vegdog完成签到,获得积分10
刚刚
陆焉识完成签到 ,获得积分10
1秒前
123高人发布了新的文献求助10
1秒前
动如脱兔完成签到,获得积分10
1秒前
1秒前
太叔千愁完成签到,获得积分10
1秒前
1秒前
zhangliyingfly完成签到,获得积分10
2秒前
zoe完成签到 ,获得积分10
2秒前
热心的张博完成签到,获得积分10
2秒前
lijia完成签到 ,获得积分20
2秒前
zzzz完成签到,获得积分10
2秒前
3秒前
焦糖咸鱼完成签到,获得积分10
3秒前
李狗蛋完成签到,获得积分10
4秒前
充电宝的应助被小七采纳,获得10
4秒前
rtaxa完成签到,获得积分0
4秒前
实验室发布了新的文献求助10
4秒前
小鸡发布了新的文献求助10
4秒前
冷傲臻完成签到,获得积分10
4秒前
4秒前
moni完成签到 ,获得积分10
4秒前
5秒前
WYJ完成签到,获得积分10
5秒前
5秒前
感动的莞发布了新的文献求助10
5秒前
zzyy完成签到,获得积分10
5秒前
sunny完成签到,获得积分10
6秒前
习二完成签到,获得积分10
6秒前
没名字完成签到 ,获得积分10
6秒前
无语发布了新的文献求助10
6秒前
NEO完成签到 ,获得积分10
7秒前
幸运周周周完成签到 ,获得积分10
7秒前
7秒前
管小海完成签到,获得积分10
7秒前
一口蛋黄苏完成签到,获得积分10
7秒前
kzt666ok完成签到,获得积分10
7秒前
ai91完成签到,获得积分10
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology)求助 1000
Encyclopedia of Modern Artificial Intelligence 1000
John McDowells Bildungstheorie 800
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
Synthesis, Application and Future Perspectives of Smart Nano-materials - Part 1 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8152442
求助须知:如何正确求助?哪些是违规求助? 9549069
关于积分的说明 21690841
捐赠科研通 7740658
什么是DOI,文献DOI怎么找? 3425157
关于科研通互助平台的介绍 2550382
邀请新用户注册赠送积分活动 2468710